Rivaban 2.5 Tablet is primarily utilised to lower the risk of stroke and systemic embolism in adults with nonvalvular atrial fibrillation, a common heart rhythm disorder. It is a novel oral anticoagulant that belongs to the class of direct factor Xa inhibitors.
In addition to this significant use, this tablet also plays an essential role in managing and preventing deep vein thrombosis (DVT) and pulmonary embolism (PE), conditions characterised by blood clots in the veins or lungs. It is further employed to reduce the likelihood of DVT and PE recurrence post initial treatment and is used for prophylaxis of these conditions in patients undergoing hip or knee replacement surgery. This medicine is also used in combination with aspirin to decrease the risk of major cardiovascular events in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).
Before starting on this medicine, it's important that you consult your doctor who will advise on the correct dosage and frequency. Make sure you inform your doctor about any preexisting conditions or ongoing medications. If you experience any side effects while using this medicine, notify your doctor straight away. To achieve optimal results, continue taking the medicine for the duration prescribed by your doctor.